Back to Atlas
BSemi-durableStandard research/education caution
CMP-0235
Regional approval/research
Selank
Anxiolytic / Nootropic
Anxiolysis and cognitive-stability positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- Tuftsin analog/enkephalin modulation
- Primary market use
- Anxiety/cognition
Pharmacology
- Molecular weight (Da)
- 751.9
- Oral bioavailability
- N/A/intranasal
- Half-life
- ~5–60 min parent peptide; analogs may be longer
- Route tags
- Route-dependent / verify
- Evidence level
- Human/Regional
- Clinical status
- Regional approval/research
- Value-for-money score
- 6 / 10
Reported protocol signal
Intranasal: • 750-1000 mcg daily in the morning (Dr. Seeds) SQ: • 100-300 mcg daily in the morning (Dr. Seeds)
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Found in supplier and EveryChem catalogs